Cargando…
Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo
Neuroblastoma (NB) is a pediatric tumor of the peripheral nervous system. Treatment of the disease represents an unsolved clinical problem, as survival of patients with aggressive form of NB remains below 50%. Despite recent identification of numerous potential therapeutic targets, clinical trials v...
Autores principales: | Krawczyk, Ewa, Hong, Sung-Hyeok, Galli, Susana, Trinh, Emily, Wietlisbach, Larissa, Misiukiewicz, Sara F., Tilan, Jason U., Chen, You-Shin, Schlegel, Richard, Kitlinska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920526/ https://www.ncbi.nlm.nih.gov/pubmed/31409888 http://dx.doi.org/10.1038/s41374-019-0297-7 |
Ejemplares similares
-
Preclinical Models of Neuroblastoma—Current Status and Perspectives
por: Krawczyk, Ewa, et al.
Publicado: (2023) -
Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance
por: Czarnecka, Magdalena, et al.
Publicado: (2014) -
Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation
por: Abualsaud, Nouran, et al.
Publicado: (2021) -
Sympathetic Neurotransmitters and Tumor Angiogenesis—Link between Stress and Cancer Progression
por: Tilan, Jason, et al.
Publicado: (2010) -
Neuropeptide Y and its Y2 Receptor – Potential Targets in Neuroblastoma Therapy
por: Lu, Congyi, et al.
Publicado: (2010)